Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?

被引:42
作者
Nguyen, T. N. [1 ,2 ,3 ,4 ]
Cumming, R. G. [4 ]
Hilmer, S. N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal N Shore Hosp, Dept Aged Care, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
关键词
atrial fibrillation; frailty; anticoagulant; anti-arrhythmic; stroke; bleeding; ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; MAJOR HEMORRHAGE; HEART-FAILURE; HIGH-RISK; WARFARIN; STROKE; DIGOXIN; IMPACT;
D O I
10.1111/imj.12912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundFrailty is common in patients with atrial fibrillation and may impact on antithrombotic and anti-arrhythmic treatment. AimTo describe differences in clinical characteristics, prescription of antithrombotic and anti-arrhythmic medications and incidence of haemorrhage and stroke, between frail and non-frail older inpatients. MethodsProspective observational study in patients aged 65years with atrial fibrillation admitted to a teaching hospital in Sydney, Australia. Frailty was assessed using the Reported Edmonton Frail Scale, stroke risk with CHA2DS2-VASc score and bleeding risk with HAS-BLED score. Participants were followed after 6months for haemorrhages and strokes. ResultsWe recruited 302 patients (mean age 84.7 7.1years, 53.3% frail, 50% female, mean CHA2DS2-VASc 4.61 +/- 1.44, mean HAS-BLED 2.97 +/- 1.04). Frail participants were older and had more co-morbidities and higher risk of stroke but not haemorrhage. Upon discharge, 55.7% participants were prescribed with anticoagulants (49.3% frail, 62.6% non-frail, P = 0.02). Thirty-three per cent received antiplatelets only and 11.1% no antithrombotics, with no difference by frailty status. For anti-arrhythmics, 52.6% received rate-control drugs only, 11.8% rhythm-control drugs only and 13.5% both and 22.1% were not prescribed either, with no difference by frailty status. On univariate logistic regression, frailty decreased the likelihood of anticoagulant prescription (odds ratio (OR) 0.58, 95%CI 0.36-0.93), but this was not significant on multivariate analysis (OR 0.66, 95%CI 0.40-1.11). After 6months, overall incidence of ischaemic stroke was 2.1%, and in patients taking anticoagulants, incidence of major/severe bleeding was 6.3%, with no significant difference between frailty groups. ConclusionsFrailty status had little impact on antithrombotic prescription and no impact on anti-arrhythmic prescription.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 60 条
[1]  
Abdel-Latif Ahmed K, 2005, J Am Med Dir Assoc, V6, P128
[2]  
[Anonymous], 2001, CIRCULATION, V104, P2118
[3]  
[Anonymous], CEREBROVASC DIS
[4]  
[Anonymous], GLOBAL HEART
[5]  
[Anonymous], EURO GERIATR MED
[6]   Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation [J].
Antani, MR ;
Beyth, RJ ;
Covinsky, KE ;
Anderson, PA ;
Miller, DG ;
Cebul, RD ;
Quinn, LM ;
Landefeld, CS .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (12) :713-720
[7]   Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis [J].
Baczek, Victoria L. ;
Chen, Wendy T. ;
Kluger, Jeffrey ;
Coleman, Craig I. .
BMC FAMILY PRACTICE, 2012, 13
[8]   The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation [J].
Bajorek, B. V. ;
Krass, I. ;
Ogle, S. J. ;
Duguid, M. J. ;
Shenfield, G. M. .
AUSTRALASIAN JOURNAL ON AGEING, 2002, 21 (01) :36-41
[9]   Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century [J].
Ball, Jocasta ;
Carrington, Melinda J. ;
McMurray, John J. V. ;
Stewart, Simon .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) :1807-1824
[10]  
Bang A, 2011, NEW ZEAL MED J, V124, P28